ECDC Profile picture
Jan 13 4 tweets 4 min read
#JustPublished!
Threat Assessment Brief: Implications for the EU/EEA of the spread of the #SARSCoV2 #Omicron XBB.1.5 sub-lineage.

Overall level of risk is low for the EU/EEA general population; moderate to high for vulnerable individuals.

Read:
bit.ly/XBB15TAB
#COVID19 Image
Mathematical modelling indicates that #XBB15 could become dominant in the EU/EEA after 1-2 months, given the current low proportions reported in the EU/EEA & its estimated growth rate.

No signals of increased severity of XBB.1.5 compared to circulating omicron sub-lineages. Image
The proportion of XBB.1.5 in EU/EEA was lower than 2.5% for the final 2 weeks of '22 (the most recent period where variant proportions at this low level can be accurately estimated).

In the US, #XBB15 is currently spreading 12% faster than other variants.
bit.ly/XBB15TAB
#XBB15 is a sub-lineage of #XBB, which evolved from two earlier lineages of #Omicron, with an additional mutation.

First detected in the US in October, has been growing in proportion in many countries around the world.

ECDC designed it as a Variant of Interest on 12.01.2023 Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with ECDC

ECDC Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ECDC_EU

Dec 12, 2022
#JustPublished!
Increase in Invasive Group A streptococcal infections among children in Europe, including fatalities .

Full press release:
ecdc.europa.eu/en/news-events…

#StrepA #iGAS
A number of European countries (IE, FR, NL, ES, SE and UK) indicate an increase seen during 2022, particularly since September, in the number of cases of invasive Group A Streptococcus (#iGAS) disease among children less than ten years of age.

#StrepA Image
During the same period, several deaths associated with #iGAS in children less than 10 years of age have also been reported. The increase has been several-fold higher than pre-pandemic levels for the equivalent period of time. 

Read more:
ecdc.europa.eu/en/news-events…

#StrepA
Read 5 tweets
Dec 7, 2021
#JustPublished!
@EMA_News and @ECDC_EU recommendations on "mix and match" vaccination courses and boosters.

Read full text here: bit.ly/3pDe6tb
Vaccines are continuing to prevent many millions of EU citizens from becoming very ill or dying and figures show that numbers of hospitalisations and deaths remain lowest in those Member States with the highest vaccination rates.

#COVID19 #VaccinesSaveLives #VaccinesWork
Due to a raise in #COVID19 infections and hospitalisations, we urge all EU citizens to get fully vaccinated and to adhere to recent recommendations on booster vaccination for #COVID19.

Recommendations on booster doses in our latest Rapid Risk Assessment: bit.ly/RRACOVID17
Read 4 tweets
Sep 1, 2021
#JustPublished!
Interim public health considerations for the provision of additional #COVID19 vaccine doses.

Read full report here: bit.ly/ECDCBoosterDoc Image
Providing all eligible individuals with the recommended dose regimen should remain the current
priority for #COVID19 vaccination programmes in the EU/EEA.

All vaccines authorised in the EU/EEA are highly protective against COVID19 related hospitalisation, severe disease & death. Image
Administering an additional vaccine dose to people who may experience a limited response to the primary #COVID19 vaccination, such as some categories
of immunocompromised individuals, should already be considered now.

bit.ly/ECDCBoosterDoc Image
Read 5 tweets
Aug 4, 2021
‼️ IMPORTANT ‼️

Vaccination is key to protecting against serious #COVID19, including disease caused by #DeltaVariant.

With @EMA_News we urge 🇪🇺 citizens to get fully vaccinated as soon as possible!

Don't forget your 2nd dose.
Don't miss your 2nd dose.

bit.ly/FullVaccination
With the increasing circulation of the #DeltaVariant in EU/EEA, #EMA & #ECDC strongly encourage those who are eligible for vaccination but have not yet been vaccinated to start and complete the recommended #COVID19 vaccination schedule soon.
Full vaccination with any of the approved vaccines = a high level of protection against severe disease and death.

The highest level of protection is achieved after enough time (7-14 days) after the last dose.

ecdc.europa.eu/en/publication…

#COVID19 #DeltaVariant
Read 6 tweets
Apr 11, 2020
#COVID19 and #FaceMasks:

We have recently updated our guidance on face masks' use.

1. Their use in the community could be considered, especially when visiting busy, closed spaces - such as grocery stores, shopping centres, or when using public transport. Image
2. They should be considered only as a 𝗖𝗢𝗠𝗣𝗟𝗘𝗠𝗘𝗡𝗧𝗔𝗥𝗬 measure, not as a replacement for #PhysicalDistancing, cough and sneeze etiquette, #HandHygiene & avoiding touching of one's face. Image
3. 𝗥𝗘𝗠𝗘𝗠𝗕𝗘𝗥! Proper use of any mask (including the home-made ones) is 𝗩𝗜𝗧𝗔𝗟, as failing to put it on or off safely may lead to an increase of probability of getting infected with #SARSCoV2! Image
Read 6 tweets
Feb 4, 2020
How can I avoid getting infected with the #coronavirus?🦠

Are face masks effective?😷

Am I protected if I had the flu shot this year? 💉

Find answers to these and many more questions on the #nCoV2019 outbreak

in our #FAQ: bit.ly/QandAnCoV2019
or in the thread below!
@ppenttin @Eurosurveillanc @WHO @WHO_Europe @EU_Commission @Europarl_EN @EUCouncilPress @POLITICOEurope @euronews @EU_Health #nCoV2019 Questions & Answers:

𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧: 𝐖𝐡𝐞𝐫𝐞 𝐝𝐨𝐞𝐬 𝐭𝐡𝐞 #coronavirus 𝐜𝐨𝐦𝐞 𝐟𝐫𝐨𝐦?

Find the answer on the slide below or in our #FAQ here: bit.ly/QandAnCoV2019
#nCoV2019 Questions & Answers:

𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧: 𝐈𝐬 𝐭𝐡𝐢𝐬 𝐯𝐢𝐫𝐮𝐬 𝐜𝐨𝐦𝐩𝐚𝐫𝐚𝐛𝐥𝐞 𝐭𝐨 #SARS 𝐨𝐫 𝐭𝐡𝐞 𝐬𝐞𝐚𝐬𝐨𝐧𝐚𝐥 #flu?

Find the answer on the slide below or in our #FAQ here: bit.ly/QandAnCoV2019
Read 28 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(